Victor J. Dzau, MD
Victor J. Dzau, MD, is president and CEO of Duke University Health System, chancellor of health affairs and James B. Duke Professor of Medicine at Duke University. He was the Hersey Professor and chairman of the Department of Medicine at Harvard, and previously chairman of the Department of Medicine at Stanford University.
Dr. Dzau is recognized nationally and globally for a long and highly decorated career as a scientist, administrator and leader. His seminal research laid the foundation for the development of cardiovascular drugs (ACE and angiotensin inhibitors) that are now being used globally for the treatment of high blood pressure, heart attack and congestive heart failure.
For his outstanding scientific contributions he has received numerous awards and recognitions including the prestigious Gustav Nylin Medal from the Swedish Royal College of Medicine, the Polzer Prize from the European Academy of Sciences & Arts, the Ellis Island Medal of Honor, and the Distinguished Scientist Award of the American Heart Association, among many others. He has been awarded six honorary degrees, and a professorship in his name has been established at Harvard University.
Dr. Dzau has made significant impacts on healthcare through his leadership in translational research, health innovation, global healthcare strategy and delivery. Under his leadership, Duke has established Duke Translational Medicine Institute, Duke Global Health Institute, Duke-NUS Medical School in Singapore and Duke Institute of Health Innovation.
As one of the world’s most preeminent academic health leaders, Dr. Dzau advises governments, businesses and universities worldwide, serving on advisory councils and boards of directors. He is a Council member of the Institute of Medicine (IOM) of the National Academy of Science USA, a member of the Board of Directors of Singapore Health System, former member of the Advisory Board of Canadian Institute for Health Research, former member of the Advisory Council to Director of National Institute of Health (NIH), chair of the NIH Cardiovascular Disease Advisory Committee and past chair of the Association of Academic Health Centers.
In 2011, he led a partnership among Duke Medicine, World Economic Forum and McKinsey & Company to establish the International Partnership for Innovative Healthcare Delivery, and chairs its Board of Directors.
In North Carolina (NC), he served on the Board of Directors and Executive Committees of the NC Biotechnology Center and the NC Chamber. He was appointed to the NC Governor’s Innovation Council and China Council and served on the NC IOM’s Health Reform Advisory Committee.